| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 04/22/2009 | CN101411750A Oral Chinese medicine for treating chronic urticaria |
| 04/22/2009 | CN101411727A Formula of pine pollen essence tablet and preparation technique thereof |
| 04/22/2009 | CN101411725A Anti-tumor halobios medicine for improving immunity function, and preparation method thereof |
| 04/22/2009 | CN101411724A Composition for preventing flocculation and delamination of bee honey and royal jelly oral liquid and processing method |
| 04/22/2009 | CN101411400A Glossy privet fruit extract for improving production performance and immunity function of laying hen and use method |
| 04/22/2009 | CN100480379C Candida albicans CTD protein kinase gene and application therefor |
| 04/22/2009 | CN100480263C Immunosuppressive receptor derived from dendritic cell, coding sequence and uses thereof |
| 04/22/2009 | CN100480242C CDK-inhibitory pyrimidines, and production and use thereof as pharmaceutical agents |
| 04/22/2009 | CN100479862C Transporters and drug delivery system by using the same |
| 04/22/2009 | CN100479814C Use of accelerated lymphocyte homing agents for manufacture of medicament for treating delayed graft function in tissue transplant |
| 04/22/2009 | CN100479805C Chinese caterpillar fungus injection preparation method |
| 04/21/2009 | US7521532 Comprises nucleotide sequences coding transmembrane protein for diagnosis and treatment immunological and autoimmune diseases |
| 04/21/2009 | US7521471 CB1cannabinoid receptor antagonists; e.g. 5-(4-chlorophenyl)-4-cyano-1-(2,4-dichlorophenyl)-N-piperidin-1-yl-1H-pyrazole-3-carboxamide; various psychological, neurodegenerative, pain and cardiovascular disorders |
| 04/21/2009 | US7521463 Immunomodulatory compounds |
| 04/21/2009 | US7521454 2-butylamino-8-hydroxy-9-(6-methyl-3-pyridylmethyl)adenine; interferon inducing activity; antiviral, antiallergic agent; immune response modulator; hepatitis B and C, asthma, atopic dermatitis |
| 04/21/2009 | US7521450 Inhibitors of kinases |
| 04/21/2009 | US7521438 Allergies,chronic obstructive airway disorders (COPD), e.g. bronchial asthma, chronic obstructive bronchitis, pulmonary emphysema with reversible obstruction, bronchial asthma and other bronchial disorders; side effect reduction |
| 04/21/2009 | US7521212 Method for producing oligopolysaccharides |
| 04/21/2009 | US7521206 Tumor necrosis factor (TNF); immunotherapy or diagnosis of TNF-related diseases such as cancer; nucleic acids, host cells, vectors |
| 04/21/2009 | US7521068 For pulmonary and nasal drug administration |
| 04/21/2009 | US7521052 Administering an effective amount of an anti-IL-6 receptor antibody (anti-IL-6R antibody) and an effective amount of methotrexate (MTX) for therapy of rheumatoid arthritis |
| 04/21/2009 | US7521051 agonists and/or antagonists of PD-1 (Programmed Death 1) thereby modulate immune responses; treating autoimmune diseases, inflammatory disorders, allergies, transplant rejection, cancer |
| 04/21/2009 | CA2362003C Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 04/21/2009 | CA2356263C Aminopyrazole derivatives |
| 04/16/2009 | WO2009048474A1 2,7,9-substituted purinone derivatives for immunosuppression |
| 04/16/2009 | WO2009048133A1 Mite antigenic rice |
| 04/16/2009 | WO2009048123A1 Bis(trimethylsilyl)phenyl compound or salt thereof, and use thereof |
| 04/16/2009 | WO2009047336A1 Phthalazine and pyrido [3,4-d] pyridaz ine compounds as h1 receptor antagonists |
| 04/16/2009 | WO2009047006A2 Amphoteric liposomes comprising neutral lipids |
| 04/16/2009 | WO2009046881A1 Use of a peptide combination including c-peptide, as a therapeutic agent |
| 04/16/2009 | WO2009046880A2 Use of a peptide as a therapeutic agent |
| 04/16/2009 | WO2009046879A2 Use of the combination of npy and nociceptin as a therapeutic agent |
| 04/16/2009 | WO2009046878A1 Tnf inhibitory peptide and cgrp as therapeutic agents |
| 04/16/2009 | WO2009046877A2 Use of a histrelin and leuprolide as therapeutic agents |
| 04/16/2009 | WO2009046875A2 Combination of splenopentin and thymopentin and the use thereof in medicine |
| 04/16/2009 | WO2009046874A1 Therapeutic combination of trh-potentiating peptide and stresscopin |
| 04/16/2009 | WO2009046873A1 Combined use of vasonatrin and gastrin-i as a therapeutic agent |
| 04/16/2009 | WO2009046872A2 Use of a peptide as a therapeutic agent |
| 04/16/2009 | WO2009046868A1 Use of a peptide as a therapeutic agent |
| 04/16/2009 | WO2009046867A2 Caerulein alone or in combination with acth (3-24 ) as therapeutic agent |
| 04/16/2009 | WO2009046866A2 Trap-14 as a therapeutic agent |
| 04/16/2009 | WO2009046865A2 Cholecystokinin-33 alone or in combination with trap-14 as therapeutic agent |
| 04/16/2009 | WO2009046864A2 Use of the human pancreatic polypeptide as a therapeutic agent |
| 04/16/2009 | WO2009046863A2 Use of thymosin alpha 1 peptide or the combination with the human pancreatic polypeptide as a therapeutic agent |
| 04/16/2009 | WO2009046862A1 Use of physalemin as a therapeutic agent |
| 04/16/2009 | WO2009046861A1 Use of cnp-22, alone1 or in combination with physalemin, as a therapeutic agent |
| 04/16/2009 | WO2009046860A2 Use of dago as a therapeutic agent |
| 04/16/2009 | WO2009046859A2 Use of af12198 and dago as therapeutic agents |
| 04/16/2009 | WO2009046858A2 Therapeutic uses of kisspeptin 13 and compositions thereof |
| 04/16/2009 | WO2009046857A1 Use of a peptide as a therapeutic agent |
| 04/16/2009 | WO2009046856A2 Use of serorphin as a therapeutic agent |
| 04/16/2009 | WO2009046853A1 Use of intermedin 47 peptide as a therapeutic agent |
| 04/16/2009 | WO2009046852A1 Therapeutic uses of intermedin 47 and 53 peptides |
| 04/16/2009 | WO2009046851A1 Cgrp as a therapeutic agent |
| 04/16/2009 | WO2009046850A1 Cgrp as a therapeutic agent |
| 04/16/2009 | WO2009046849A1 Use of the peptide cecropin a as a therapeutic agent |
| 04/16/2009 | WO2009046848A1 Use of the peptide thymosin beta 4 alone or in combination with cecropin a as a therapeutic agent |
| 04/16/2009 | WO2009046847A2 Use of peptide ll-37 as a therapeutic agent |
| 04/16/2009 | WO2009046846A2 Use of il-1 receptor peptide, alone or in combination with peptide ll-37, as a therapeutic agent |
| 04/16/2009 | WO2009046845A2 Use of a lactoferrin partial peptide peptide as a therapeutic agent |
| 04/16/2009 | WO2009046844A1 Therapeutic uses of peptide tdvngdgrhdl |
| 04/16/2009 | WO2009046843A1 Therapeutic uses of peptides kvlpvpq and/or tdvngdgrhdl |
| 04/16/2009 | WO2009046835A1 Use of goserelin and amylin as therapeutic agents |
| 04/16/2009 | WO2009046834A2 Use of t140 and optionally retrocyclin-1 as therapeutic agents for the treatment of m. tuberculosis infections |
| 04/16/2009 | WO2009046833A1 Use of a peptide as a therapeutic agent |
| 04/16/2009 | WO2009046832A2 Short peptides used in medicine |
| 04/16/2009 | WO2009046831A1 Use of a peptide as a therapeutic agent |
| 04/16/2009 | WO2009046830A1 Use of a peptide as a therapeutic agent |
| 04/16/2009 | WO2009046829A2 Casoxin d as a therapeutic agent |
| 04/16/2009 | WO2009046827A2 Use of growth hormone-releasing factor and/or mage-3 antigen (271-279) as therapeutic agents |
| 04/16/2009 | WO2009046826A1 Use of a cyclic penta-peptide as a therapeutic agent |
| 04/16/2009 | WO2009046825A1 Use of a peptide acetyl-calpastatin as a therapeutic agent |
| 04/16/2009 | WO2009046824A2 Use of apelin-12 as a therapeutic agent, eg for treating excessive angiogenesis |
| 04/16/2009 | WO2009046823A1 Exendin-3 and apelin-12 for therapeutic applications |
| 04/16/2009 | WO2009046822A2 Use of the peptide ymdgtmsqv as a therapeutic agent |
| 04/16/2009 | WO2006012359A3 Methods for inducing the differentiation of blood monocytes into functional dendritic cells |
| 04/16/2009 | WO2005042727A3 Methods of organ regeneration |
| 04/16/2009 | US20090099341 Heparanase specific molecular probes and their use in research and medical applications |
| 04/16/2009 | US20090099259 Method for regulating gene expression |
| 04/16/2009 | US20090099237 Methods of treating inflammatory diseases |
| 04/16/2009 | US20090099190 Kinase inhibitors useful for the treatment of proliferative diseases |
| 04/16/2009 | US20090099185 P38 Map Kinase Inhibitors |
| 04/16/2009 | US20090099171 Diazaquinolones that inhibit prolyl hydroxylase activity |
| 04/16/2009 | US20090099157 Tetrahydro-pyrazolo-pyridine thioether modulators of cathepsin s |
| 04/16/2009 | US20090099083 Compositions for eliciting an immune response against mycobacterium avium subspecies paratuberculosis |
| 04/16/2009 | US20090098609 Il-2 fusion proteins with modulated selectivity |
| 04/16/2009 | US20090098218 2-(1-amino-cyclobutylmethyl)-8-(4-methoxy-phenyl)-4,5-dihydro-1 H-1,7,9-triazacyclopenta[a]naph-thalene-3-carboxylic acid lactame; useful especially as inhibitors of mitogen-activated protein kinase-activated protein kinase-2 (MK2 or MAPKAP kinase-2 |
| 04/16/2009 | US20090098216 Arsenic therapy for apls-type autoimmune lymph-oproliferative syndrome in mice and humans |
| 04/16/2009 | US20090098200 Compositions comprising lipophilic active compounds and method for their preparation |
| 04/16/2009 | US20090098167 PHL P 1 Allergen Derivative |
| 04/16/2009 | US20090098161 removal of structural features of HIV that interfere with immune response. In particular, sialic acid is removed to enhance immune recognition and to impair Complement Factor H binding, CD55 and CD59 removal prevent the binding of Complement Factor H; Acquired Immunodeficiency Syndrome |
| 04/16/2009 | US20090098158 Porcine cirocvirus type 2 (PCV2); Actinobacillus pleuropneumoniae, Haemophilus parasuis, Mycoplasma hyrhinis, Mycoplasma hyopneumoniae, Pasteurella multocida, Salmonella spp., Strepococcus suis |
| 04/16/2009 | US20090098153 Activation of HCV-specific T cells |
| 04/16/2009 | US20090098142 Methods and compositions for treating and monitoring treatment of IL-13-associated disorders |
| 04/16/2009 | US20090098120 Compositions and methods for the treatment of immune related diseases |
| 04/16/2009 | US20090098116 Immunogenic compositions for induction of anti-tumor immunity |
| 04/16/2009 | US20090098112 Novel antibodies |
| 04/16/2009 | DE102008009752A1 Beverage for improving the state of health, contains chili pepper juice and grape fruit juice that are mixed to the beverage without alcohol |
| 04/16/2009 | CA2702400A1 Mite antigenic rice |
| 04/16/2009 | CA2702293A1 Probiotics for use in relieving symptoms associated with gastrointestinal disorders |